Abstract
KSI-301 is a new intravitreal anti-vascular endothelial growth factor (VEGF) antibody biopolymer conjugate under investigation for the treatment of ag......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
